Breaking News Instant updates and real-time market news.

MRSN

Mersana Therapeutics

$15.32

0.46 (3.10%)

07:06
02/15/18
02/15
07:06
02/15/18
07:06

Mersana Therapeutics initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay started Mersana Therapeutics with a Buy rating and $33 price target. The analyst believes XMT-1522's differentiation versus Kadcyla could build a case for a more compelling clinical profile and expanded commercial outlook.

  • 12

    Mar

MRSN Mersana Therapeutics
$15.32

0.46 (3.10%)

07/24/17
COWN
07/24/17
INITIATION
COWN
Outperform
Mersana Therapeutics initiated with an Outperform at Cowen
Cowen analyst Boris Peaker initiated Mersana Therapeutics with an Outperform telling investors it uses two proprietary platforms to generate high drug-to-antibody ratio ADCs with desirable drug properties. The company's lead candidate, XMT-1522, is currently in a Phase I trial and he expects Mersana shares to appreciate as '1522 demonstrates a favorable clinical profile and validates the two platform technologies.
07/24/17
JPMS
07/24/17
INITIATION
Target $23
JPMS
Overweight
Mersana Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Jessica Fye started Mersana Therapeutics with an Overweight rating and $23 price target. The analyst views the company's antibody drug conjugate platform as differentiated with the potential to develop a "number of novel pipeline assets."
07/24/17
LEER
07/24/17
INITIATION
Target $23
LEER
Outperform
Mersana Therapeutics initiated with an Outperform at Leerink
Leerink analyst Michael Schmidt started Mersana Therapeutics with an Outperform rating and $23 price target. The analyst believes multi-target partnerships with Takeda and Merck KGaA validate the company's approach.

TODAY'S FREE FLY STORIES

RMD

ResMed

$112.85

-2.54 (-2.20%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
ResMed subsidiary Brightree acquires Apacheta, terms not disclsoed »

Brightree announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWE

WWE

$72.61

-1.06 (-1.44%)

, SKYAY

Sky

$0.00

(0.00%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
WWE, Sky extend partnership in New Zealand »

WWE (WWE) and SKY (SKYAY)…

WWE

WWE

$72.61

-1.06 (-1.44%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OSTK

Overstock.com

$17.20

-0.77 (-4.28%)

09:11
12/17/18
12/17
09:11
12/17/18
09:11
Hot Stocks
Overstock.com, tZERO to develop commodity contract token for GSR Capital »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$127.55

-5.3 (-3.99%)

09:10
12/17/18
12/17
09:10
12/17/18
09:10
Downgrade
Centene rating change  »

Centene downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CMTL

Comtech

$25.63

-0.38 (-1.46%)

09:10
12/17/18
12/17
09:10
12/17/18
09:10
Hot Stocks
Comtech receives $3.6M renewal agreement »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$59.42

0.235 (0.40%)

, ESS

Essex Property Trust

$262.24

0.51 (0.19%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Recommendations
CyrusOne, Essex Property Trust, Gaming and Leisure Properties, Hudson Pacific, Prologis, Regency Centers, SBA Communications, Store Capital analyst commentary  »

North American REIT…

CONE

CyrusOne

$59.42

0.235 (0.40%)

ESS

Essex Property Trust

$262.24

0.51 (0.19%)

GLPI

Gaming and Leisure Properties

$34.85

0.45 (1.31%)

HPP

Hudson Pacific

$30.08

-0.14 (-0.46%)

PLD

Prologis

$64.31

-0.35 (-0.54%)

REG

Regency Centers

$61.52

-0.74 (-1.19%)

SBAC

SBA Communications

$172.53

0.26 (0.15%)

STOR

Store Capital

$30.85

0.05 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

AGS

PlayAGS

$22.37

0.13 (0.58%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
PlayAGS to acquire Integrity Gaming for $49M in cash »

PlayAGS announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$61.75

-3.13 (-4.82%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
Icahn Automotive to acquire RPM Automotive, terms not disclosed »

Icahn Automotive Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNJN

Finjan Holdings

$2.70

(0.00%)

, JNPR

Juniper

$27.77

-0.335 (-1.19%)

09:09
12/17/18
12/17
09:09
12/17/18
09:09
Hot Stocks
Jury finds non-infringement of Claim 10 of Finjan's '494 patent by Juniper »

Finjan Holdings (FNJN)…

FNJN

Finjan Holdings

$2.70

(0.00%)

JNPR

Juniper

$27.77

-0.335 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AGS

PlayAGS

$22.37

0.13 (0.58%)

09:07
12/17/18
12/17
09:07
12/17/18
09:07
Hot Stocks
Breaking Hot Stocks news story on PlayAGS »

PlayAGS to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

09:06
12/17/18
12/17
09:06
12/17/18
09:06
Hot Stocks
BAE Systems receives $96.6M U.S. Army contract modification »

BAE Systems has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPM

RPM

$60.45

0.2 (0.33%)

09:06
12/17/18
12/17
09:06
12/17/18
09:06
Hot Stocks
RPM acquires Siamons International, terms not disclosed »

RPM International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

NTRP

Neurotrope

$4.08

-0.18 (-4.23%)

09:05
12/17/18
12/17
09:05
12/17/18
09:05
Hot Stocks
Neurotrope announces publication of data from Phase 2 study of Bryostatin-1 »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$93.78

-1.7 (-1.78%)

, SSNLF

Samsung

$0.00

(0.00%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Hot Stocks
Medtronic announces FDA approval of InterStim smart programmer »

Medtronic (MDT) announced…

MDT

Medtronic

$93.78

-1.7 (-1.78%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.12

0.035 (0.17%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
Vodafone rating change  »

Vodafone upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BT

BT Group

$15.93

-0.095 (-0.59%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
BT Group rating change  »

BT Group upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GG

Goldcorp

$9.14

-0.315 (-3.33%)

09:03
12/17/18
12/17
09:03
12/17/18
09:03
Upgrade
Goldcorp rating change  »

Goldcorp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$192.06

-5.41 (-2.74%)

09:02
12/17/18
12/17
09:02
12/17/18
09:02
Hot Stocks
Amgen submits BLA for ABP 710 to FDA »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

MET

MetLife

$38.90

-0.62 (-1.57%)

09:01
12/17/18
12/17
09:01
12/17/18
09:01
Recommendations
MetLife analyst commentary  »

MetLife price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

IONS

Ionis Pharmaceuticals

$52.97

-0.52 (-0.97%)

09:00
12/17/18
12/17
09:00
12/17/18
09:00
Recommendations
Ionis Pharmaceuticals analyst commentary  »

Needham names Ionis a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

09:00
12/17/18
12/17
09:00
12/17/18
09:00
Technical Analysis
Technical Take: Financial Select Sector at new 52-week low »

The Financial Select…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
12/17/18
12/17
09:00
12/17/18
09:00
General news
Treasury Action: yields stabilized above lows »

Treasury Action: yields…

08:58
12/17/18
12/17
08:58
12/17/18
08:58
General news
Futures pointing to extension of Friday selloff »

Stock futures are trading…

ADBE

Adobe

$230.00

-17.71 (-7.15%)

08:57
12/17/18
12/17
08:57
12/17/18
08:57
Conference/Events
RBC Capital Internet analysts to hold an analyst/industry conference call »

Internet Analysts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 07

    Jan

LITE

Lumentum

$43.46

-0.4 (-0.91%)

, OCLR

Bought by LITE

$0.00

(0.00%)

08:56
12/17/18
12/17
08:56
12/17/18
08:56
Recommendations
Lumentum, Bought by LITE analyst commentary  »

Lumentum can continue…

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Bought by LITE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.